Literature DB >> 29754939

Incremental risk of long-term mortality with increased burden of comorbidity in hospitalized patients with pneumonia.

Mohammed Yousufuddin1, Jessica Shultz2, Taylor Doyle2, Hamid Rehman3, Mohammad Hassan Murad4.   

Abstract

BACKGROUND: Patients hospitalized for pneumonia often have concurrent comorbid conditions (CCs). The influence of CCs on the risk of subsequent death is not fully understood.
METHODS: We examined adults hospitalized for pneumonia between 1996 through 2015 at Mayo Clinic for the presence of 20 priori selected CCs. We estimated cumulative all-cause mortality by number of CCs using multivariable Cox regression model.
RESULTS: Study comprised of 9580 adults (age 70 ± 17.0 years, men 53%, whites 88%) with median number of CCs 3 (interquartile 1-4), and overall deaths 6032 (62.9%) during 50,934 person-years of follow up (118.5 deaths/1000 person-years). After adjustment, any single comorbid condition was associated with 9% greater risk of death (95% confidence interval 1.08-1.11, P < 0.0001). When study cohort was stratified according to number of comorbidities (none, 1, 2, 3, 4, 5, and ≥6 CCs), the risk of death increased as the number of CCs increased (33 for no CCs vs 252 deaths for ≥6 CCs per 1000 person-years).
CONCLUSIONS: Long-term mortality after hospitalization for pneumonia increases as the burden of comorbidities increases. Therefore, a simple comorbidity count help improve prognostic accuracy in identifying patients at increased risk of death following an episode of pneumonia.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comorbidity; Mortality; Pneumonia

Mesh:

Year:  2018        PMID: 29754939     DOI: 10.1016/j.ejim.2018.05.003

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study.

Authors:  Mohammed Yousufuddin; Umesh M Sharma; Sumit Bhagra; Mohammad Hassan Murad
Journal:  BMJ Open Respir Res       Date:  2021-03

2.  Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project.

Authors:  Guobin Su; Marco Trevisan; Junichi Ishigami; Kunihiro Matsushita; Cecilia Stålsby Lundborg; Juan Jesus Carrero
Journal:  Nephrol Dial Transplant       Date:  2020-11-01       Impact factor: 5.992

Review 3.  Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics.

Authors:  Marina Dukhinova; Elena Kokinos; Polina Kuchur; Alexey Komissarov; Anna Shtro
Journal:  Cytokine Growth Factor Rev       Date:  2020-12-03       Impact factor: 7.638

4.  Urgent need of a management plan for survivors of COVID-19.

Authors:  Bartolome Celli; Leonardo M Fabbri
Journal:  Eur Respir J       Date:  2020-04-23       Impact factor: 16.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.